Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems

J Control Release. 2017 Sep 28:262:284-295. doi: 10.1016/j.jconrel.2017.08.004. Epub 2017 Aug 5.

Abstract

The potential for use of polymers in controlled drug delivery systems has been long recognized. Since their appearance in the literature, a wide range of degradable and non-degradable polymers have been demonstrated in drug delivery devices. The significance and features of ethylene-vinyl acetate (EVA) copolymers in initial research and development led to commercial drug delivery systems. This review examines the breadth of EVA use in drug delivery, and will aid the researcher in locating key references and experimental results, as well as understanding the features of EVA as a highly versatile, biocompatible polymer for drug delivery devices. Topics will include.

Keywords: API; Biologic; Controlled release; Core Sheath; Drug; EVA; Ethylene vinyl acetate copolymer; Extrusion; Intravaginal; Long Acting; Matrix; Melt; Ophthalmic; Oral; Peptide; Polymer; Subcutaneous Implant; Sustained release; Thermoplastic; Zero order release.

Publication types

  • Review

MeSH terms

  • Animals
  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / chemistry
  • Drug Delivery Systems*
  • Humans
  • Polyvinyls / administration & dosage*
  • Polyvinyls / chemistry

Substances

  • Delayed-Action Preparations
  • Polyvinyls
  • ethylenevinylacetate copolymer